RICHMOND, VA — Governor Glenn Youngkin announced AstraZeneca, a global biopharmaceutical company focused on the research, development, and commercialization of prescription medicines, selected Virginia for its largest single facility investment ever as part of their plan to invest $50 billion in the United States by 2030. At the announcement, Governor Youngkin was joined by AstraZeneca CEO Pascal Soriot and company leadership, …
Read More »July- Governor Glenn Youngkin Announces AstraZeneca Selects Virginia for Multi-Billion Dollar Manufacturing Center
